EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Phosphoproteomic Profiling Reveals Stage‐Specific Signalling and Metabolism in Equine Melanocytic Neoplasm

Paitoon Srimontri iD, Amornthep Kingkaw iD, Nawarus Prapaiwan iD, Rangsima Sujittosakul iD, Nichapat Iamkaewprasert iD, Jiraschaya Piputwat iD, Puetta Isama-Al iD, Thanutchanok Munkongdee iD, Thanapon Chotikaprakal iD, Petchpailin Yanyongsirikarn iD, Narumon Phaonakrop iD, Sittiruk Roytrakul iD und 2 weitere

Veterinary and Comparative Oncology · 2026-09 · 24 (3) · 468-484

DOI: 10.1111/vco.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 16.04.2026. Verfasst von Paitoon Srimontri und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand. Hauptthemen laut MEDLINE: Horse Diseases, Melanoma, Phosphoproteins, Skin Neoplasms. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University's Strategic Research Fund: 2023, Faculty of Veterinary Science, Mahidol University., Faculty of Veterinary Science, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Equine melanocytic neoplasms (EMN) are aggressive tumours characterised by high metastatic potential and limited therapeutic options available. However, the molecular mechanisms underlying their progression remain poorly understood. This study therefore presents the integrative phosphoproteomic analysis of EMN tissue, with the aim of elucidating stage‐specific alterations in signalling pathways and metabolism. Nineteen tissue samples from grey horses were categorised as normal‐stage ( n = 6), early‐stage EMN ( n = 7), and severe‐stage EMN ( n = 6) and subjected to in‐depth analysis using liquid chromatography–tandem mass spectrometry (LC–MS/MS). A total of 2035 phosphoproteins were identified, of which 219 were differentially expressed across the disease stages. Interestingly, early‐stage EMN showed dysregulation of inositol phosphate metabolism and activation of the PI3K‐Akt pathway which involved INPP5F and PKN2. In severe‐stage EMN, upregulation of SYNJ1, STRN4 and VIM indicated enhanced membrane trafficking, cytoskeletal remodelling, and MAPK signalling. Additionally, ASPM and GNAO1 upregulation reflected heightened proliferation and altered Rap1 signalling, while UBR5 dysregulation suggested aberrant protein homeostasis. Metabolic reprogramming was also noticed, with elevated TKT and GAPDH expression supporting glycolysis and NADPH production. Observably, the severe‐stage EMN exhibited a higher expression of Dickkopf‐3 (DKK3) which suggests a role in aberrant Wnt/β‐catenin activation and tumour progression. These findings reveal stage‐specific molecular mechanisms in EMN pathogenesis and highlight potential biomarkers and therapeutic targets for equine melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Horse DiseasesMelanomaPhosphoproteinsSkin NeoplasmsAnimalsHorsesSignal TransductionProteomicsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

PI3K‐Akt signallingWnt/β‐catenin pathwayequine melanocytic neoplasmgrey horsesphosphoproteomics

Substanzen

Phosphoproteins

Autor:innen und Institutionen

  • Department of Clinical Science and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand.
  • Kasetsart University International College (KUIC), Kasetsart University, Bangkok, Thailand.
  • Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand.
  • Biochemistry Unit, Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
  • Equine Clinic, Prasuarthon Small Animal Hospital, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand.
  • Functional Proteomics Technology Laboratory, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathum Thani, Thailand.

ORCID-Profile: Paitoon Srimontri, Amornthep Kingkaw, Nawarus Prapaiwan, Rangsima Sujittosakul, Nichapat Iamkaewprasert, Jiraschaya Piputwat, Puetta Isama-Al, Thanutchanok Munkongdee, Thanapon Chotikaprakal, Petchpailin Yanyongsirikarn, Narumon Phaonakrop, Sittiruk Roytrakul, Wanwipa Vongsangnak, Parichart Tesena

Förderung

  • Mahidol University's Strategic Research Fund: 2023
  • Faculty of Veterinary Science, Mahidol University.
  • Faculty of Veterinary Science, Chulalongkorn University

Zitieren

APA

Srimontri, P., Kingkaw, A., Prapaiwan, N., Sujittosakul, R., Iamkaewprasert, N., Piputwat, J., Isama-Al, P., Munkongdee, T., Chotikaprakal, T., Yanyongsirikarn, P., Phaonakrop, N., Roytrakul, S., Vongsangnak, W., & Tesena, P. (2026). Integrative Phosphoproteomic Profiling Reveals Stage‐Specific Signalling and Metabolism in Equine Melanocytic Neoplasm. Veterinary and Comparative Oncology, 24(3), 468-484. https://doi.org/10.1111/vco.70070

Vancouver

Srimontri P, Kingkaw A, Prapaiwan N, Sujittosakul R, Iamkaewprasert N, Piputwat J, et al. Integrative Phosphoproteomic Profiling Reveals Stage‐Specific Signalling and Metabolism in Equine Melanocytic Neoplasm. Veterinary and Comparative Oncology. 2026;24(3):468-484. doi:10.1111/vco.70070

BibTeX
@article{Srimontri2026,
  author = {Srimontri, Paitoon and Kingkaw, Amornthep and Prapaiwan, Nawarus and Sujittosakul, Rangsima and Iamkaewprasert, Nichapat and Piputwat, Jiraschaya and Isama-Al, Puetta and Munkongdee, Thanutchanok and Chotikaprakal, Thanapon and Yanyongsirikarn, Petchpailin and Phaonakrop, Narumon and Roytrakul, Sittiruk and Vongsangnak, Wanwipa and Tesena, Parichart},
  title = {Integrative Phosphoproteomic Profiling Reveals Stage‐Specific Signalling and Metabolism in Equine Melanocytic Neoplasm},
  journal = {Veterinary and Comparative Oncology},
  year = {2026},
  volume = {24},
  number = {3},
  pages = {468--484},
  doi = {10.1111/vco.70070}
}
Kostenlos starten →